STOCK-BASED COMPENSATION EXPENSE (Tables)

3 Months Ended

Mar. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Based Compensation expense

	Three months ended March 31,
	2024		2023
Cost of revenue	$	38	$	19
Research and development		47		20
Selling		27		11
General and administrative		155		85
Total	$	267	$	135

Schedule of Weighted Average Assumptions

Stock price	$	4.75
Exercise price	$	4.75
Dividend yield		0	%
Expected volatility		77	%
Risk-free interest rate		4.12	%
Expected life (in years)		6.00

Schedule of Stock Options Awards

The following table summarizes stock options awards for the three months ended March 31, 2024:

				Weighted
	Stock Option			Average
	Awards			Exercise
	(in shares)			Price
Outstanding at January 1, 2024		846,875		$	8.20
Granted		5,000			4.75
Forfeited		(10,000	)		8.01
Outstanding at March 31, 2024		841,875			8.18

Schedule of Outstanding and Exercisable Options Ranges of Exercise Prices

The following table summarizes information about the outstanding and exercisable options at March 31, 2024 by ranges of exercise prices:

		Options Outstanding								Options Exercisable
				Weighted		Weighted						Weighted
				Average		Average						Average
Exercise		Number		Remaining		Exercise		Intrinsic		Number		Exercise		Intrinsic
Price Range		Outstanding		Contractual		Price		Value		Exercisable		Price		Value
$	4.00-7.00		462,125		7.6	$	4.55	$	144,275		194,750	$	4.48	$	68,931
$	7.01-10.00		20,000		4.1	$	8.07	$	-		20,000	$	8.07	$	-
$	10.01-13.00		130,000		3.4	$	10.62	$	-		122,500	$	10.55	$	-
$	13.01-16.00		229,750		9.0	$	14.11	$	-		58,375	$	14.11	$	-